These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 28099838)
21. Aggrecanase degradation of type III collagen is associated with clinical knee pain. Bay-Jensen AC; Kjelgaard-Petersen CF; Petersen KK; Arendt-Nielsen L; Quasnichka HL; Mobasheri A; Karsdal MA; Leeming DJ Clin Biochem; 2018 Aug; 58():37-43. PubMed ID: 29702061 [TBL] [Abstract][Full Text] [Related]
22. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Valdes AM; Meulenbelt I; Chassaing E; Arden NK; Bierma-Zeinstra S; Hart D; Hofman A; Karsdal M; Kloppenburg M; Kroon HM; Slagboom EP; Spector TD; Uitterlinden AG; van Meurs JB; Bay-Jensen AC Osteoarthritis Cartilage; 2014 May; 22(5):683-9. PubMed ID: 24576742 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of a pretreatment method for two-dimensional gel electrophoresis of synovial fluid using cartilage oligomeric matrix protein as a marker. Kong MK; Min BH; Lee PC J Microbiol Biotechnol; 2012 May; 22(5):654-8. PubMed ID: 22561860 [TBL] [Abstract][Full Text] [Related]
25. Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine. Swearingen CA; Carpenter JW; Siegel R; Brittain IJ; Dotzlaf J; Durham TB; Toth JL; Laska DA; Marimuthu J; Liu C; Brown DP; Carter QL; Wiley MR; Duffin KL; Mitchell PG; Thirunavukkarasu K Osteoarthritis Cartilage; 2010 Sep; 18(9):1150-8. PubMed ID: 20633682 [TBL] [Abstract][Full Text] [Related]
27. Magnetic Capture of a Molecular Biomarker from Synovial Fluid in a Rat Model of Knee Osteoarthritis. Yarmola EG; Shah Y; Arnold DP; Dobson J; Allen KD Ann Biomed Eng; 2016 Apr; 44(4):1159-69. PubMed ID: 26136062 [TBL] [Abstract][Full Text] [Related]
28. Osteoarthritis year in review 2016: imaging. Boesen M; Ellegaard K; Henriksen M; Gudbergsen H; Hansen P; Bliddal H; Bartels EM; Riis RG Osteoarthritis Cartilage; 2017 Feb; 25(2):216-226. PubMed ID: 27965137 [TBL] [Abstract][Full Text] [Related]
29. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis. Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441 [TBL] [Abstract][Full Text] [Related]
30. Platelet-Rich Plasma Increases Anti-inflammatory Markers in a Human Coculture Model for Osteoarthritis. Osterman C; McCarthy MB; Cote MP; Beitzel K; Bradley J; Polkowski G; Mazzocca AD Am J Sports Med; 2015 Jun; 43(6):1474-84. PubMed ID: 25716226 [TBL] [Abstract][Full Text] [Related]
31. [Application of biomarker CTX- II in osteoarthritis]. Wang XZ; Gao NY; Liu T; Shen J; Wei SP; Zheng YX; Cao YL; Zhan HS Zhongguo Gu Shang; 2013 Mar; 26(3):260-3. PubMed ID: 23795452 [TBL] [Abstract][Full Text] [Related]
32. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis. He Y; Manon-Jensen T; Arendt-Nielsen L; Petersen KK; Christiansen T; Samuels J; Abramson S; Karsdal MA; Attur M; Bay-Jensen AC Osteoarthritis Cartilage; 2019 Apr; 27(4):611-620. PubMed ID: 30654118 [TBL] [Abstract][Full Text] [Related]
33. Osteoarthritis biomarkers: year in review. Watt FE Osteoarthritis Cartilage; 2018 Mar; 26(3):312-318. PubMed ID: 29107060 [TBL] [Abstract][Full Text] [Related]
34. Osteoarthritis year in review 2019: biomarkers (biochemical markers). van Spil WE; Szilagyi IA Osteoarthritis Cartilage; 2020 Mar; 28(3):296-315. PubMed ID: 31887390 [TBL] [Abstract][Full Text] [Related]
35. An update on the pathophysiology of osteoarthritis. Mobasheri A; Batt M Ann Phys Rehabil Med; 2016 Dec; 59(5-6):333-339. PubMed ID: 27546496 [TBL] [Abstract][Full Text] [Related]
36. The evolving role of biomarkers for osteoarthritis. Ishijima M; Kaneko H; Kaneko K Ther Adv Musculoskelet Dis; 2014 Aug; 6(4):144-53. PubMed ID: 25342994 [TBL] [Abstract][Full Text] [Related]
37. Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Lafeber FP; van Spil WE Osteoarthritis Cartilage; 2013 Oct; 21(10):1452-64. PubMed ID: 23954702 [TBL] [Abstract][Full Text] [Related]
38. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Huebner JL; Kraus VB Osteoarthritis Cartilage; 2006 Sep; 14(9):923-30. PubMed ID: 16679035 [TBL] [Abstract][Full Text] [Related]
39. The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. Larsson S; Englund M; Struglics A; Lohmander LS Osteoarthritis Cartilage; 2012 May; 20(5):388-395. PubMed ID: 22330175 [TBL] [Abstract][Full Text] [Related]
40. A systematic review of the small molecule studies of osteoarthritis using nuclear magnetic resonance and mass spectroscopy. Jaggard MKJ; Boulangé CL; Akhbari P; Vaghela U; Bhattacharya R; Williams HRT; Lindon JC; Gupte CM Osteoarthritis Cartilage; 2019 Apr; 27(4):560-570. PubMed ID: 30287397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]